# Nuevocor: Research, Singapore, Singapore

> Nuevocor: Nuevocor is a biotechnology company based in Singapore, founded in 2020. Based in Singapore, Singapore. Founded 2021.

Source: https://millionrounds.com/startup/nuevocor (Millionrounds; every figure on the page links to its filing or article)

Singapore · [Research startup](https://millionrounds.com/companies)

# Nuevocor

Nuevocor is a biotechnology company based in Singapore, founded in 2020.

Email

Funding reported Last round: Undisclosed round

Research Singapore, Singapore

Follow Nuevocor and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fnuevocor)

Company summary

- **Founded:** 2021 5 years old
- **Team:** 29 11 to 50 people
- **Funding reported:** 45M as listed, currency not stated
- **Last round:** Undisclosed round Nov 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Nuevocor has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Nuevocor

Nuevocor is a biotechnology company based in Singapore, founded in 2020.

It specializes in developing genetic medicines aimed at treating untreatable cardiomyopathies, which are aggressive heart muscle diseases. The company employs a mechanobiology-centered approach that targets the underlying mechanical defects of these conditions, rather than just individual gene mutations. Nuevocor has received FDA clearance for its lead candidate, NVC-001, an AAV-based gene therapy designed to address LMNA-related dilated cardiomyopathy, a severe genetic heart condition. The company has raised $80.6 million in funding, including a $24 million Series A and a $45 million Series B round, to support its clinical development efforts. With a team of approximately 29 employees, Nuevocor is expanding its operations into Europe and serves the healthcare sector, focusing on patients with genetic heart conditions that currently lack effective treatments.

## What company datasets say Nuevocor raised

Funding, as reported

Reported in all **45M** in the source's currency

Rounds **2**

Last round **Undisclosed round**

Last round size **45M**

Last round date **Nov 2022**

Investors listed **5**

## Founders and team

From Nuevocor's own website: 3 on the team.

- **Albert Gianchetti** Chief Executive Officer
- **Cheryl Lee** VP, Operations
- **Chris Campbell** Senior VP, Technical Operations

## On a portfolio page

Investors who name them

- [KurmaPartners](https://millionrounds.com/fund/kurmapartners)

Each firm lists Nuevocor on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

mechanical defect correction health care genetic medicine biotechnology research nvc-001 genetic mutations medical research biotech collaborations disease modifier targeting hospital & health care medical aav gene therapy gene therapy health biotechnology biomechanical pathways

Built with from their website

Google Cloud Viewport Meta ORCA AVA Varnish webpack Google Cloud Hosting Priority Hints React Microsoft Exchange Sirvoy

+8 more

Wix eCommerce Microsoft 365 Apps & Services WebsiteBuilder Mobile Friendly Lodash Open Graph PROS Airtable

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** Singapore
- **Revenue:** 1M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/nuevocor)

## Research in Singapore

Startups like it

- [**Lion TCR** Singapore · founded 2015 *Raised*](https://millionrounds.com/company/lion-tcr)
- [**Hummingbird Bioscience** Singapore · founded 2015 *Raised*](https://millionrounds.com/company/hummingbird-bioscience)
- [**NalaGenetics** Singapore · founded 2016 *Raised*](https://millionrounds.com/company/nalagenetics)
- [**Novotech** Singapore · founded 1997](https://millionrounds.com/startup/novotech)
- [**Tessa Therapeutics Ltd** Singapore · founded 2012](https://millionrounds.com/startup/tessa-therapeutics-ltd)
- [**Genecast** Singapore · founded 2014](https://millionrounds.com/startup/genecast-3)
- [**Esco** Singapore · founded 1978](https://millionrounds.com/startup/esco-4)
- [**Engine Biosciences** Singapore · founded 2014](https://millionrounds.com/startup/engine-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Nuevocor in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)